(Q34781573)

4 August 2017

title

Metabolic syndrome--what is the clinical usefulness? (English)

1 reference

4 August 2017

1 reference

Richard Kahn

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

22 May 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

371

1 reference

4 August 2017

issue

9628

1 reference

4 August 2017

page(s)

1892-1893

1 reference

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Does a diagnosis of metabolic syndrome have value in clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Metabolic syndrome: a multiplex cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Critical questions about the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

The metabolic syndrome: is this diagnosis necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960731-X

7 January 2021

10.1016/S0140-6736(08)60731-X

Identifiers

DOI

1 reference

4 August 2017

1 reference